Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying kickbacks to doctors who agreed to prescribe its HIV drugs. The settlement announced on Tuesday by U.S. Attorney Jay Clayton …
Source: Claims Journal